In our previous study, the human cervical carcinoma cell line HeLa-Ohio (HeLa) was cultured in the presence of progressively greater concentrations of an anti-microtubule agent, vinblastine sulfate (VLB), a typical substrate of MDR1, in the culture medium, and its multidrug resistant subline, Hvr100-6, was successively established.
6) The induction of MDR1 was demonstrated by flow cytometric analysis, and by its cross-resistance to other vinca alkaloids, anthracyclines, taxans and others. 6) To date, a number of transcriptional factors have been proposed to be involved in MDR1 expression, including EGR1, 7) NF-IL6 8) and NF-R2. 9) The effects of C/EBPb, 10) NF-kB, 11) insulin, 11) EGF, 12) TNF-a 13) and doxorubicin 14) were also proposed in rodents or on a cellular basis. Since these endogenous and exogenous factors will be associated with up-or down-regulation of various proteins other than MDR1, MDR1 overexpression is expected to be accompanied by changes of several unknown factors.
Recent advances in genomics have allowed us to inspect the alterations in the expression levels of thousands of genes simultaneously by cDNA microarray. 15, 16) Two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (2-D SDS-PAGE) followed by mass spectrometry of the excised protein spots also has rapidly become the operating paradigm for proteome analysis. 17, 18) In the present study, the genes and proteins differentially expressed in HeLa and Hvr100-6 cells were screened using cDNA microarray and proteome analyses, respectively, and sorcin, a soluble resistance-related calcium-binding protein of 22 kDa protein, was identified to be important in relation to MDR1 overexpression. To obtain the information on the relationship between MDR1 and sorcin, their mRNA expression levels and the activity of caspase-3 were evaluated in HeLa cells treated with small interfering RNAs (siRNAs) targeted for MDR1 and sorcin mRNAs, which recognize complementary mRNAs, resulting in their degradation. The siRNAs-mediated RNA interference has been widely used to analyze the function of targeted genes. ). Hvr100-6 (passage 82-87) was established by the stepwise exposure to VLB, as described before, 6) and maintained in the culture medium additionally supplemented with 100 nM VLB. HeLa and Hvr100-6 cells (4 and 12ϫ10 4 cells/cm 2 , respectively) were seeded into culture flasks (Nunclon TM flasks, Nalge Nunc International, NY, U.S.A.), grown in a humidified atmosphere of 5% CO 2 -95% air at 37°C, and subcultured every 3 or 4 d with 0.05% trypsin-0.02% EDTA (Invitrogen Corp.).
Knock-down of Sorcin Induces Up-regulation of MDR1 in HeLa Cells
For cDNA microarray and 2-D SDS-PAGE analyses, cell pellets of HeLa and Hvr100-6 cells were prepared 5 d after seeding of 2.0ϫ10 4 and 6.0ϫ10 4 cells/cm 2 , respectively, in 10 ml of complete culture medium without and with 100 nM vinblastine, respectively, in 100 mm culture dishes, and stored at Ϫ80°C prior to analysis.
The HCT-15 cell line was obtained from Dainippon Sumitomo Pharma Co., Ltd. (Osaka, Japan). HCT-15 cells (passage 57) were maintained in culture medium consisting of RPMI-1640 medium (GlutaMAX ™ Supplement I with L-glutamine (2 mM) and sodium bicarbonate (2 mg/ml); Cat. No. 31800-014, Invitrogen Corp., Carlsbad, CA, U.S.A.) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Lot. No. AGM7413, HyClone, UT, U.S.A.).
cDNA Microarray Analysis TaKaRa human 3K DNA CHIP Version 3.0 (TaKaRa Bio Inc., Japan) was used in the analysis of the gene expression profile in HeLa and Hvr100-6 cells. This array consists of a TaKaRa IntelliGene TM Human Cancer Chip Version. 3.0, Cancer DD Chip, Cytokine Chip, Human 1K Chip, and a little extra, i.e. about 3000 cDNA fragments associated with human cancer, 12 kinds of house keeping genes for positive controls and for normalization of two fluorescent signals and 9 kinds of bacteria, phage, and plant genes for negative controls. A list is available at http://www.takara-bio.com. Total RNA was extracted from the frozen cell pellets using an RNeasy Mini kit (Qiagen, Hilden, Germany) and an RNase-Free DNase Set (Qiagen). Subsequently, poly(A) ϩ mRNA was purified with oligotexdT30 (TaKaRa Bio Inc., Japan), followed by the preparation of the cDNA probes and their hybridization to the microarray slides according to manufacturer's protocol (TaKaRa Bio Inc.). cDNA probes from HeLa cells and Hvr100-6 cells were labeled with Cy5-dCTP and Cy3-dCTP, respectively. After washing the slides, the array filters were scanned using an Affymetrix 428 Array Scanner and quantitated using ImaGene Ver 4.2 (BioDiscovery, Inc., Tokyo, Japan) software. For each analysis, the spot intensity was normalized by subtracting the background signal using the spot intensities of seven housekeeping genes; 1. Beta-actin (GenBank Accession No. NM_001101); 2. Glyceraldehyde-3-phosphate dehydrogenase (NM_002046); 3. Major histocompatibility complex, class I, A (NM_002116); 4. Glucose-6-phosphate dehydrogenase (NM_000402); 5. Ribosomal protein S5 (NM_001009); 6. General transcription factor IIB (M76766); and 7. ATP synthase, Hϩ transporting, mitochondrial F0 complex, subunit b, isoform 1 (NM_001688). In addition to normalization, the cutoff value was set as the sum of their average and 2-fold that of their standard deviation. Genes were excluded from further investigation in the cases that the signal intensities in both Cy3 and Cy5 were lower than the cutoff value, or that the signal intensity ratio of Cy3 and Cy5 was less than 2. If the signal intensity only in one of the slides was under the cutoff value, the ratio was described as "Detectable" or "Undetectable". The analysis was performed in triplicate, and the genes giving the same results were adopted as the data.
Two-Dimensional Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (2-D SDS-PAGE) The frozen cell pellets were homogenized with a 5 times volume of lysis buffer consisting of 5 M urea, 2 M thiourea, 2% CHAPS, 2% SB3-10, 1% dithiothreitol and 2% Ampholine. Protein concentrations were measured using a Protein Assay system (Bio-Rad Laboratories, Richmond, CA, U.S.A.). One hundred microgram of samples were subjected overnight to Immobiline Drystrip (Amersham Biosciences) using in-gel rehydration. 21, 22) The rehydrated gels were then gently dried with tissue paper to remove the excess fluid, and isoelectric focussing (IEF) was performed in a Hoefer Multiphor II electrophoresis chamber (Amersham Biosciences) according to the manufacturer's instructions. 2-D SDS-PAGE was performed in 9-18% acrylamide gradient gels using a Hoefer IsoDalt electrophoresis chamber (Amersham Biosciences). The gels were stained with SYPRO Ruby (Bio-Rad Laboratories) according to the manufacturer's protocol. 18, 23) The SYPRO Ruby stained proteins were detected using the Molecular Imager FX (Bio-Rad Laboratories), and were subjected to in-gel digestion. Database management was performed using ImageMaster 2D Platinum image analysis software from Amersham Biosciences.
In-gel Digestion and Mass Spectrometric (MS) Identification of Proteins As described in the previous reports, 18, 23) protein spots were excised from the gels using clean scalpels, and were washed twice with Milli-Q water and dehydrated in 100% acetonitrile (ACN) until they turned an opaque white. The spots were then dried in a vacuum centrifuge, and subsequently rehydrated in 10 ml of digestion solution consisting of 50 mM NH 4 HCO 3 , 5 mM CaCl 2 and 0.1 mg/ml modified sequence-grade trypsin (Promega, Madison, WI, U.S.A.). After incubation for 16 h at 37°C, the digestion was terminated by adding 10 ml of 5% trifluoroacetic acid (TFA). Peptides were extracted 3 times for 20 min with 50 ml of 5% TFA and 50% ACN, and the extracts were pooled and dried in a vacuum centrifuge. The dried materials were resuspended in 10 ml of 0.1% TFA. To remove the excess salts from the extracts, solid-phase extraction was performed using a C 18 ZipTip (Millipore, Billerica, MA, U.S.A.) according to the manufacturer's instructions. Peptides were eluted from the ZipTip using 3 ml of 50% ACN and 0.1% TFA, and 1 ml of the eluants were spotted onto a target plate. The spots on the target plate were immediately mixed with 0.5 ml of a matrix solution containing 0.3 mg/ml a-cyano-hydroxycinnamic acid, 33% acetone and 66% ethanol, and were completely air-dried at room temperature. MS and MS/MS spectra were obtained using an Ultraflex TOF/TOF mass spectrometer (Bruker Daltonics, Ibaraki, Japan). An external peptide mixture was used to calibrate the instrument. The identification of proteins was carried out using the MASCOT software (Matrix Science, Boston, MA, U.S.A.) with the NCBInr database.
siRNA Transfection siRNA duplexes for MDR1 and sorcin mRNA were synthesized by FASMAC, Co. (Kanagawa, Japan): MDR1 (GenBank accession no. NM_000927): sense (5Ј-GAA GGA AAA GAA ACC AAC UdTdT-3Ј), antisense (5Ј-AGU UGG UUU CUU UUC CUU CdTdT-3Ј) 20) ; sorcin (GenBank accession no. NM_003130): sense (5Ј-CUC AGG AUC CGC UGU AUG GdTdT-3Ј), antisense (5Ј-CCA UAC AGC GGA UCC UGA GdTdT-3Ј). Scramble siRNA for sorcin was also designed based on the original sorcin target sequence: 5Ј-UGC CUG CCU GCG GAG AUU AdTdT-3Ј. A mixture of 4 ml of Oligofectamine Reagent (Invitrogen Corp.) and 11 ml of Opti-MEM I Reduced-Serum Medium (Invitrogen Corp.) were incubated at room temperature for 10 min. After that, 180 ml of Opti-MEM I Reduced-Serum Medium and 5 ml of each 20 mM siRNA solution dissolved in distilled water was added, and the mixture was incubated at room temperature for 20 min, giving 200 ml of siRNA-Oligofectamine complexes for HeLa cells. A mixture of 2.67 ml of Oligofectamine Reagent (Invitrogen Corp.) and 12.33 ml of Opti-MEM I Reduced-Serum Medium (Invitrogen Corp.) were incubated at room temperature for 10 min. After that, 180 ml of Opti-MEM I Reduced-Serum Medium and 5 ml of each 20 mM siRNA solution dissolved in distilled water were added, and the mixture was incubated at room temperature for 20 min, giving 200 ml of siRNA-Oligofectamine complexes for HCT-15 cells.
HeLa cells and HCT-15 cells were plated on a 6-well plate at 2ϫ10 5 and 1.5ϫ10 5 cells/well, respectively, and incubated in the culture medium without kanamycin sulfate for 24 h. The cells were washed twice with phosphate buffered saline (PBS), and supplied with 800 ml Opti-MEM I ReducedSerum Medium and 200 ml siRNA-Oligofectamine complexes. After incubation for 4 h, the medium was replaced with fresh culture medium without kanamycin sulfate. The cells were subsequently cultured for 1 to 3 d, and their respective pellets were prepared for the quantification of the target mRNAs. In the case of the measurement of the caspase-3 activity, HeLa cells were plated on a 100-mm culture dish at 2ϫ10 6 cells/dish and treated with a 5-fold volume of siRNA-Oligofectamine complexes and related reagents used for the mRNA quantification. Control cell pellets were treated with Oligofectamine Reagent instead of the siRNAOligofectamine complexes, and were also used as the authentic standard in each run of the mRNA quantification. No significant effect of Oligofectamine Reagent treatment was observed as compared with untreated control cultures (data not shown). The cell pellets were stored at Ϫ80°C until assay.
Reverse Transcription (RT) and Real Time Quantitative Polymerase Chain Reaction (PCR) Total RNA was extracted using an RNeasy Mini kit (Qiagen) and an RNaseFree DNase Set (Qiagen), and RT and real-time quantitative PCR were performed as described previously. 24) Primers and TaqMan probes were designed using the Primer Express 1.0 program (Applied Biosystems, Foster City, CA, U.S.A.). The primers and TaqMan probe for sorcin mRNA were as follows: forward primer (5Ј-GAA AGA TCA CCT TCG ACG ACT ACA T-3Ј), reverse primer (5Ј-GGG AAA TTC ACA ACA CCT TGC T-3Ј) and TaqMan probe (5Ј-AGC AGT ATC CCG TCT TCG AAA GCT GTC TGT AAG-3Ј). The primer and TaqMan probe set for MDR1 mRNA was used as reported previously. 25) Primers and the TaqMan probe for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from Applied Biosystems (TaqMan GAPDH Control Reagent Kit). The mRNA level of caspase-3 was measured with a Real Time PCR Kit for Human Caspase 3 Gene Expression kit (Maxim Biotech, Inc., San Francisco, CA, U.S.A.) according to the manufacturer's protocol. In each run of the assay, the mRNAs of MDR1, sorcin, caspase-3 and GAPDH were analyzed in five-fold serially diluted samples from an authentic cell sample. The mRNA levels of MDR1, sorcin and caspase-3 are expressed as relative levels to GAPDH mRNA.
Flow Cytometry The function of MDR1 was evaluated in the cells treated with sorcin siRNA and scrambled siRNA using the rhodamine 123 (Molecular Probes, Inc., Eugene, OR, U.S.A.) assay, as described previously. 26) Briefly, the cell concentration of the cell suspension was adjusted to be 2ϫ10 6 cells/ml in warmed Hanks' balanced salt solution (HBSS; 137 mM NaCl, 5.4 mM KCl, 1.3 mM CaCl 2 , 0.4 mM MgSO 4 , 0.5 mM MgCl 2 , 0.3 mM Na 2 HPO 4 , 0.4 mM KH 2 PO 4 , 4.2 mM NaHCO 3 , 5.6 mM glucose, 0.06 mM phenol red and 25 mM HEPES), and 1 ml was placed in 2 ml tubes, followed by incubation with or without 5 mg/ml cyclosporine A (CsA) for 1 h at 37°C in a 5% CO 2 humidified atmosphere, and subsequently by the preparation of cell pellets. Soon thereafter, the pellets were washed once with HBSS and resuspended in fresh HBSS containing 1 mM rhodamine 123. After incubation for 30 min at 37°C, the cell suspension was once washed and resuspended in ice-cold PBS at a concentration of 1ϫ10 6 cells/ml with final concentration 0.25 mg/ml of 7-aminoactinomycin D (7-AAD; Wako Pure Chemical Industries) to assess the cell viability. The fluorescent intensity of aliquots of 1ϫ10 4 cells was determined using a BD FACSCalibur TM Flow Cytometry System (BD Biosciences, Franklin Lakes, NJ, U.S.A.). Analysis was performed for rhodamine 123 (em. 530 nm) and 7-AAD (em. 650 nm). The mean rhodamine 123 fluorescence determined for a homogenous population of the cells were adopted as the data, after the mathematical exclusion of 7-AAD-positive cells. The data were expressed as the ratio of fluorescence intensity with CsA to that without CsA, indicating CsA inhibitable efflux of rhodamine 123.
Caspase-3 Activity The caspase-3 activity in the cell lysate was measured using an EnzChek ® Caspase-3 Assay Kit #1 (Molecular Probes, Invitrogen Corp.) as described previously. 24, 27) Briefly, treated cells were washed twice with ice-cold PBS, collected, suspended in the cell lysis buffer, which was a component of the kit, and subjected to a freezethaw cycle. As directed by the instruction manual, the lysates were then centrifuged at 5000 rpm for 5 min in a microcentrifuge and the transferred supernatants subjected to assay of the caspase-3 activity. Fluorescence was measured using a Fluoroskan Ascent FL (Thermo Electron Corporation, Waltham, MA, U.S.A.) with excitation at 355 nm and emission at 460 nm.
Statistical Analysis Data are shown as the meanϮstan-dard deviation. Statistical analysis was performed using the statistical package SPSS ver. 8.0 (SPSS Inc., Chicago, IL, U.S.A.). The significance of the difference between the mean values of the expression levels of mRNA for MDR1 and sorcin was calculated using the unpaired t-test. For multiple comparisons, statistic analyses were performed with the Tukey-Kramer test. p values of less than 0.05 (two-tailed) were considered significant. Table 1 lists the genes differentially expressed between HeLa cells and its MDR1-overexpressing multidrug resistant subline, Hvr100-6 cells. Table 2 lists the genes up-or downregulated in Hvr100-6 cells when compared with HeLa cells. A total of 148 known and unknown genes in the GenBank were identified as those with differential expression levels between HeLa and Hvr100-6 cells. Of these candidate genes, the ratios of Cy5/Cy3 and Cy3/Cy5 were more than 2 for the 47 and 7 genes, respectively (Table 1) , and 93 genes were upregulated, whereas only one gene was down-regulated (Table   1068 Vol. 30, No. 6 2). These candidate genes included the intracellular transducers, cell cycle-related proteins, stress-responsive proteins, cell-cell adhesion receptors, extracellular matrix homeostasis-related proteins and regulators of the development and function of the immune system. The gene expression of MDR1 was up-regulated with a ratio of 56.9Ϯ10.8, consistent with our previous study determined using a real time quantitative PCR method, 24) and the degree of the regulation was much higher than those in other genes; thus, MDR1, as an efflux pump, contributes to more so to the vinblastine-resistance. Also, the following genes were more than 4-fold up-regulated in Hvr100-6 cells, compared with those in HeLa cells (Table 1) . The complement component 4-binding protein (C4BP) alpha is a component of C4BP that plays a physiological role in the regulation of the complement on the surface of apoptotic cells. 28) Sorcin is a soluble resistance-related calcium-binding protein of 22 kDa and has been shown to be up-regulated in several MDR1 expressing lymphocytes or drug-resistant tumor cells. [29] [30] [31] [32] Transforming growth factor, beta-induced, 68 kD (TGFBI ), which is also referred to as BIGH3, encodes the protein keratoepithelin, and amino acid substitutions within this gene cause most of cases of the corneal dystrophies (CDs) such as granular CD, Avellino CD and lattice CD type I (LCD I). 33, 34) Glutathione S-transferase (GST) M4 belongs to the family of the human Mu class GSTs, which plays a significant role in the Phase II detoxication of electrophilic compounds, including carcinogens and therapeutic drugs, by conjugation with glutathione. 35, 36) The gene expression of asparagine synthetase ubiquitously expressed in most mammalian cells is increased in response to either amino acids or glucose starvation, and the asparagines synthetase activity is suggested to be associated with the efficacy of L-asparaginase in the treatment of hematological diseases. 37, 38) Among these, sorcin was also identified as a differentially expressed protein between HeLa and Hvr100-6 cells by proteome analysis, including 2-D SDS-PAGE, in-gel digestion and mass spectrometric identification of proteins, which has recently been given attention as the operating paradigm (Fig. 1) .
RESULTS AND DISCUSSION
Sorcin was first discovered as a gene amplified together with the MDR1 gene in multidrug-resistant cancer cells. 29) A positive correlation between MDR1 and sorcin expression has been reported in multidrug-resistant sublines selected with a wide variety of anticancer drugs and acute myeloid leukemia samples. [30] [31] [32] Although little information is available on the rule of sorcin, Parekh et al. reported that sorcin overexpression was associated with a lower sensitivity for paclitaxel, similarly to MDR1. 39) Here, the effects of siRNAs for MDR1 and sorcin mRNA on their mRNA expression levels in HeLa cells were evaluated to obtain more information about their regulatory mechanisms. As shown in Fig. 2A , the siRNA for MDR1 mRNA resulted in its decrease by 86% and 61% on days 1 and 2 after the treatment, whereas the expression level of sorcin mRNA was not changed in Hela cells. The siRNA for sorcin mRNA suppressed the expression of sorcin itself by 80-90% on days 1-3 after the treatment; however, a more than 3-fold increase of the expression level for MDR1 mRNA was observed in Hela cells (Fig. 2B) . In the HCT-15 cells expressing MDR1 endogenously (Fig.  2C) , siRNA for sorcin mRNA significantly reduced the expression of sorcin itself on days 1-3 after the treatment. On the other hand; no significant difference was detected in the expression of MDR1 in the HCT-15 cells between the treatments with siRNA for sorcin and scramble siRNA.
The function of MDR1 was evaluated by flow cytometric analysis using rhodamine 123 as a probe. The CsA-dependent fluorescence intensity of rhodamine 123 showed a tendency to be increased in the sorcin knock-down HeLa cells compared with that in the cells treated with scramble siRNA, although statistically significant changes were not detected up to 3 d after the siRNA treatment (Fig. 3A) . The increment in the fluorescence intensity of rhodamine 123 in the HCT-15 cells was lower than that in the HeLa cells (Fig. 3B) . Thus, the sorcin knock-down appeared to enhance the efflux function of MDR1. Vinblastine has the potential to increase the calcium ion channel activity, followed by the increase of the intracellular calcium concentration, 40) which is probably suitable for the up-regulation of sorcin. In addition, Tan and coworkers have speculated the role of sorcin as a co-factor of MDR1 to involve the following steps: (1) the binding of sorcin with intracellular calcium results in the decreasing of cellular calcium (2) a decrease in the activity of phosphatase (3) an increase in MDR1 phosphorylation and activity. 32) These might explain the higher expression of MDR1 and sorcin in stable vinblastine-resistant cells, although not fully the upregulation of MDR1 induced by the knock-down of sorcin in the present study. The change of the intracellular condition by the knock-down of sorcin seemed to have the advantage of the up-regulation of MDR1 expression, and sorcin might be partly responsible for constitutively stopping the up-regulation of MDR1 expression. Taken together, these results suggested that sorcin knock-down resulted in MDR1 up-regulation, thereby the promotion of MDR1 function. Qi et al., have identified sorcin in multidrug resistant leukemia cell line. They suggested that sorcin over-expression in leukemia cells increased resistance to cytotoxic agent-induced apoptosis with decrease of calcium concentrations. 41) In HeLa cells, the activation of caspase-3 was involved in the cytotoxic agent-induced apoptosis.
42) There- Level of MDR1 and sorcin mRNA relative to GAPDH mRNA were determined by real-time quantitative PCR. GAPDH was selected as an endogenous RNA control to normalize for differences in the amount of total RNA. Open circles and squares show the data for MDR1 and sorcin mRNA, respectively. Closed circles and squares show the data for MDR1 and sorcin mRNA, respectively, in scramble siRNA-treated cells. Each point represents the average and standard deviation of the respective relative concentration of three independent experiments. * Statistically significant difference (p<0.05) compared with the value in scramble siRNA-treated cells. fore, we investigated effects of sorcin on the expression and the activity of caspase-3. The mRNA level of caspase-3 in the sorcin knock-down HeLa cells was significantly elevated on day 3 as compared to that in the cells treated with scramble siRNA (Fig. 4A) . In the HCT-15 cells (Fig. 4B) , no significant difference was detected in the mRNA level of caspase-3 between the treatments with siRNA for sorcin and scramble siRNA. Furthermore, the sorcin knock-down increased 2-3 fold in the caspase 3 activity (Table 3) . Combined with the report of Qi et al., the present study gave rise to a possibility that the down-regulation of sorcin might elevated the intracellular level of calcium, activated caspase-3, and could induce apoptosis. [43] [44] [45] Zhou et al. have reported that knock-down of sorcin with siRNA increased sensitivity to cytotoxic-agents in leukemia cells, 46) suggesting the down-regulation of MDR1. However, whether the knock-down of sorcin affect the MDR1 expression levels or not has not yet been reported. Therefore, we focused on the regulation of MDR1 expression by sorcin in the present study. On the contrary to the prediction, the knock-down of sorcin induced the up-regulation of MDR1 mRNA. The effect of the sorcin knock-down on the expression of MDR1in Hela cells might be different from that in leukemia cells. Alternatively, factors beyond MDR1 might be involved in the chemoresistance.
In conclusion, we have identified sorcin as one of the genes differentially expressed in HeLa and MDR1-overexpressing Hvr100-6 cells. Interestingly, we have found that the down-regulation of sorcin caused the up-regulation of MDR1, but not vice versa. Furthermore, we confirmed the suppressive effect of sorcin on apoptosis. a) Each value represents the meanϮstandard deviation of more than three independent experiments. b) p<0.05, significantly different from the untreated control value. c) Relative ratio represents the ratio of the value in the sorcin siRNA-treated cells to that in the scrample siRNA-treated cells.
